Contact us
About company
Neurophyxia's main objective is to develop 2-iminobiotin (or 2-IB) as a novel injectable pharmaceutical product to reduce the deleterious effects of oxygen shortage in the brain occurring in two life-threatening conditions:
BE
Unknown
Not verified company
Business transparency
- Did not verified company info
- Ask their customers for reviews
- Did not replied to negative reviews